A previous study demonstrated that knockout of FOXM1 significantly retards tumor growth and colonization of p53-null lymphoma and sarcoma cells in the lungs.71 FOXM1 also has been shown to control the expression of genes to promote cell proliferation, invasiveness, metabolism, and drug resistance.72–75. This evidence concerns the gene TP53 and lymphoma.